- Retraction Note
- Open Access
- Published:
Retraction Note: eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
Retrovirology volume 11, Article number: 16 (2014)
References
Han D, Habte H, Qin Y, Takamoto K, LaBranche C, Montefiori D, Cho MW: Eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER. Retrovirology. 2012, 9 (Suppl 2): 362-10.1186/1742-4690-9-S2-P362. http://www.retrovirology.com/content/9/S2/P362,
The Office of Research Integrity, US Department of Health and Human Services: Updated 23rd December 2013. Case Summary: Han, Dong-Pyou. http://ori.hhs.gov/content/case-summary-han-dong-pyou,
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found at 10.1186/1742-4690-9-S2-P362
Rights and permissions
Open Access  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Han, D., Habte, H., Qin, Y. et al. Retraction Note: eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER. Retrovirology 11, 16 (2014). https://doi.org/10.1186/1742-4690-11-16
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/1742-4690-11-16